Glimijoy MP 2mg/500mg/15mg Tablet
Marketer
Vjovis Health Care Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimijoy MP 2mg/500mg/15mg Tablet
Metformin/Glibenclamide/Pioglitazone 2mg/500mg/15mg tablets offer a combined approach to managing elevated blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, leading to reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food is recommended to mitigate potential stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, skip the missed dose and resume your usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects may encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment is standard before initiating therapy. Limit alcohol consumption to minimize the potential for increased side effects.
Uses of Glimijoy MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimijoy MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glimijoy MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
Common Side effects of Glimijoy MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimijoy MP 2mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glimijoy MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this tablet with food.
How Glimijoy MP 2mg/500mg/15mg Tablet works:
Glimijoy MP 2mg/500mg/15mg tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct pathways to optimize blood sugar management when monotherapy or dual-agent regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimijoy MP 2mg/500mg/15mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Glimijoy MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimijoy MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant clinical evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when prescribing Glimijoy MP 2mg/500mg/15mg tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. The use of Glimijoy MP 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimijoy MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. This medication is contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Glimijoy MP 2mg/500mg/15mg Tablet :
Should you forget a Glimijoy MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimijoy MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently